Leucine-rich alpha-2 glycoprotein reflects transmural inflammation assessed by through-the-scope endoscopic ultrasonography: A prospective study in small-bowel Crohn’s disease

Figure 5 Kaplan-Meier analysis. A-D: Crohn’s disease-related hospitalization-free survival in the overall cohort stratified by total wall thickness (TWT) ≥ 2.65 mm (A), leucine-rich alpha-2 glycoprotein (LRG) ≥ 14.68 μg/mL (B), submucosal thickness (SMT) ≥ 0.95 mm (C), LRG ≥ 15.80 μg/mL (D); E-H: Relapse-free survival among patients in clinical remission stratified by TWT ≥ 2.65 mm (E), LRG ≥ 13.99 μg/mL (F), SMT ≥ 0.95 mm (G), LRG ≥ 15.72 μg/mL (H). LRG: Leucine-rich alpha-2 glycoprotein; TWT: Total wall thickness; SMT: Submucosal thickness.